University Hospital Grenoble
Grenoble, France
NCT Number: NCT05392972
The objective of this study was to determine whether there was an association between the resilience of anesthesia professionals in the operating room of the Grenoble University Hospital and perceived work-related stress.
Looking for future studies?
Notify MeAll sexes
Observational
Grenoble, France
This trial will be conducted at the Grenoble Alpes University Hospital (CHUGA). Volunteer anesthesiologists, anesthesia interns, nurse anesthetists and nurse anesthetist students will answer questionnaires evaluating resilience, perceived stress in the last month, sleep quality, number of hours worked in the month, number of night hours and will evaluate each working day the perceived stress with the visual analogical scale of stress over 3 periods of the working day
The main objective is to determine if there is an association between the resilience (questionnaire: Connord davidson resielience scale: CDRISC10) of the anesthesia professionals in the block of the CHUGA and the perceived stress at work (Perceived stress sacle 10: PSS10).
The secondary objectives are to study the association between:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Criteria for non-inclusion:
Assessment of stress, resilience and associated factors in anesthesia professionals
Time frame: at day 0
Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.
Time frame: at day 30
The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.
Time frame: Each work day at the start of the shift. From day 0 to day 30.
Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).
Time frame: Every working day at the end of the shift. From day 0 to day 30.
Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).
Time frame: Every working day at the end of the shift. From day 0 to day 30.
Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).
Time frame: at day 30
The PSQI contains 19 self-assessed questions. These 19 questions combine to yield 7 components: (1) subjective sleep quality, (2) sleep latency, (3) sleep duration, (4) habitual sleep efficiency, (5) sleep disturbance, (6) use of sleeping medication, and (7) daytime dysfunction. Each component gives a score from 0 to 3 points (0 indicates no difficulty, while 3 indicates major difficulty). The scores of the seven components are then added together to give an overall score of 0 to 21 points (0 indicating no difficulty, and 21 indicating major difficulty).
Time frame: Each work day at the end of the service. From day 0 to day 30.
number of hours worked during the working day
Time frame: Each night of work at the end of the service. From day 0 to day 30.
the number of hours worked during the work night
University Hospital, Grenoble
Other
Acronym: StressBloc
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599436
Behavior, Dyssomnias
Ankara, Turkey (Türkiye)
View Trial DetailsNCT02591303
Dyssomnias, Insomnia
Bordeaux, France
View Trial DetailsNCT07398521
Dyssomnias, Mental Disorders
Las Vegas, Nevada, United States
View Trial DetailsNCT06102096
Anxiety, Anxiety Disorders
Stockholm, Sweden
View Trial Details